Court Halts Boehringer’s COPD Inhaler Comparative Claims Vs. GSK Products

 
• By Brenda Sandburg
  
Inhaler
Court enjoins Boehringer Ingelheim from making false and misleading statements about GSK's dry powder inhalers
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Marketing & Advertising

More from Compliance